HIGHLIGHTS
- who: Ryo Okuyama from the College of International Management, Ritsumeikan Asia Pacific University, Beppu, Japan have published the research work: Nurturing Deep Tech to Solve Social Problems: Learning from COVID-19 mRNA Vaccine Development, in the Journal: Pathogens 2022, 1469 of /2022/
- what: In this paper, I examine how BioNTech and Moderna were founded and how they obtained funding, and discuss the implications of the investment in vaccine development for both companies. The project is funded to the tune of USD 10 million and conducted through a partnership between the Departments of Health and Human . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.